Efficacy and safety of ainuovirine versus efavirenz combination therapies with lamivudine/tenofovir disoproxil fumarate for medication of treatment-naïve HIV-1-positive adults: week 48 results of a randomized controlled phase 3 clinical trial followed by an open-label setting until week 96-Reference-Cited by-同舟云学术

Efficacy and safety of ainuovirine versus efavirenz combination therapies with lamivudine/tenofovir disoproxil fumarate for medication of treatment-naïve HIV-1-positive adults: week 48 results of a randomized controlled phase 3 clinical trial followed by an open-label setting until week 96

Published:2023-07 Issue: Volume:36 Page:100769
ISSN:2666-6065
Container-title:The Lancet Regional Health - Western Pacific
language:en
Short-container-title:The Lancet Regional Health - Western Pacific

Author:

Su Bin,Gao Guiju,Wang Min,Lu Yanqiu,Li Linghua,Chen Chen,Chen Yuanyuan,Song Chuan,Yu Fengting,Li Ying,Liu Yixin,Luo Yang,He Haolan,Cheng Cong,Xu Lixia,Zhang Tong,Sun Lijun,Liu An,Xia Wei,Qin Yuanyuan,Zhao Qingxia,Wei Hongxia,Cai Weiping,Chen Yaokai,Zhang Fujie^ORCID,Wu Hao

Publisher

Elsevier BV

Subject

Infectious Diseases,Psychiatry and Mental health,Geriatrics and Gerontology,Public Health, Environmental and Occupational Health,Obstetrics and Gynecology,Health Policy,Pediatrics, Perinatology and Child Health,Internal Medicine

Reference31 articles.

1. Update of recommendations on first- and second-line antiretroviral regimens;WHO,2019

2. Dolutegravir plus two different prodrugs of tenofovir to treat HIV;Venter;N Engl J Med,2019

3. Virologic outcomes among adults with HIV using integrase inhibitor-based antiretroviral therapy;Lu;AIDS,2022

4. Chinese guidelines for diagnosis and treatment of HIV/AIDS (2021);Chin J AIDS STD,2021

5. Efavirenz--still first-line king?;Best;Expet Opin Drug Metabol Toxicol,2008

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impacts of ainuovirine-based and efavirenz-based antiretroviral therapies on the lipid profile of HIV/AIDS patients in southern China: a real-world study;Frontiers in Medicine;2024-01-08

2. Current drugs for HIV-1: from challenges to potential in HIV/AIDS;Frontiers in Pharmacology;2023-10-26

3. Pharmacokinetics and Safety of Ainuovirine/Lamivudine/Tenofovir Combination Tablets in Young and Elderly Patients with Human Immunodeficiency Virus-1 Infection;Infectious Diseases and Therapy;2023-10

4. Pharmacokinetic and Bioequivalence Evaluation of Single‐Tablet and Separate‐Tablet Regimens for Ainuovirine, Lamivudine, and Tenofovir Disoproxil Fumarate in Chinese Healthy Subjects;Clinical Pharmacology in Drug Development;2023-07-20